OSIMERT is used for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive (NSCLC) which have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy, as determined by an approved test.
The uploaded content will be moved to this newly created album. You must create an account or היכנס if you want to edit this album later on.
__privacy_notes__
